FDA panel rejects plan to administer Pfizer's Covid booster doses to public

FDA panel rejects plan to administer Pfizer's Covid booster doses to public

An influential Food and Drug Administration advisory committee on Friday resoundingly rejected a plan to administer booster shots of Pfizer and BioNTech’s Covid-19 vaccine to the general public, saying they needed more data.